Cidel Asset Management Inc. Takes Position in Haleon PLC Sponsored ADR $HLN

Cidel Asset Management Inc. acquired a new position in Haleon PLC Sponsored ADR (NYSE:HLN) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 450,689 shares of the company’s stock, valued at approximately $4,043,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Bank of America Corp DE raised its holdings in Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after purchasing an additional 6,669,923 shares during the period. JPMorgan Chase & Co. increased its position in Haleon by 15.5% in the second quarter. JPMorgan Chase & Co. now owns 8,776,686 shares of the company’s stock worth $91,014,000 after buying an additional 1,174,813 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Haleon by 6.5% in the second quarter. Envestnet Asset Management Inc. now owns 7,857,196 shares of the company’s stock worth $81,479,000 after buying an additional 476,823 shares during the period. Acadian Asset Management LLC lifted its position in shares of Haleon by 3,031.5% during the 2nd quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock valued at $55,813,000 after buying an additional 5,212,711 shares in the last quarter. Finally, Raymond James Financial Inc. grew its stake in shares of Haleon by 0.7% during the 2nd quarter. Raymond James Financial Inc. now owns 4,315,180 shares of the company’s stock valued at $44,748,000 after acquiring an additional 29,287 shares during the period. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Up 0.3%

Shares of HLN stock opened at $11.20 on Friday. The company’s fifty day simple moving average is $10.18 and its two-hundred day simple moving average is $9.71. Haleon PLC Sponsored ADR has a 52 week low of $8.71 and a 52 week high of $11.42. The stock has a market cap of $49.85 billion, a P/E ratio of 28.71 and a beta of 0.19. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48.

Analyst Upgrades and Downgrades

A number of research firms have commented on HLN. Deutsche Bank Aktiengesellschaft cut shares of Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a research report on Tuesday, January 20th. HSBC raised shares of Haleon from a “hold” rating to a “strong-buy” rating in a report on Wednesday, January 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Thursday, January 22nd. Finally, Morgan Stanley restated an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Haleon has a consensus rating of “Moderate Buy” and a consensus target price of $12.33.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.